• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor: Cautious interpretation of the association between finite treatment and better prognosis in initially HBeAg-negative hepatitis B patients with cirrhosis.

作者信息

Deng Rui, Wang Ziyan, Liu Yuxin, Sun Jian

机构信息

State Key Laboratory of Organ Failure Research, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Guangdong Provincial Clinical Research Center for Viral Hepatitis, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.

出版信息

Hepatology. 2024 Apr 1;79(4):E107-E108. doi: 10.1097/HEP.0000000000000654. Epub 2023 Oct 31.

DOI:10.1097/HEP.0000000000000654
PMID:37906598
Abstract
摘要

相似文献

1
Letter to the Editor: Cautious interpretation of the association between finite treatment and better prognosis in initially HBeAg-negative hepatitis B patients with cirrhosis.
Hepatology. 2024 Apr 1;79(4):E107-E108. doi: 10.1097/HEP.0000000000000654. Epub 2023 Oct 31.
2
Reply: Cautious interpretation of the association between finite treatment and better prognosis in initially HBeAg-negative hepatitis B patients with cirrhosis.
Hepatology. 2024 Apr 1;79(4):E109-E110. doi: 10.1097/HEP.0000000000000662. Epub 2023 Oct 31.
3
Letter to the Editor: Benefits of stopping therapy in patients with cirrhotic hepatitis B, true effect or residual confounding?致编辑的信：乙型肝炎肝硬化患者停止治疗的益处，是真实效果还是残余混杂因素？
Hepatology. 2024 Mar 1;79(3):E95-E96. doi: 10.1097/HEP.0000000000000639. Epub 2023 Oct 20.
4
[The prospective study of the clinical features and outcome of HBeAg-negative and HBeAg-positive cirrhosis in patients with chronic type B hepatitis].[慢性乙型肝炎患者中HBeAg阴性和HBeAg阳性肝硬化的临床特征及预后的前瞻性研究]
Zhonghua Yi Xue Za Zhi. 2007 Jul 10;87(26):1832-5.
5
Letter to the Editor: Retreatment Decision for Hepatitis B Flare in HBeAg-Negative Chronic Hepatitis B.
Hepatology. 2021 May;73(5):2081-2082. doi: 10.1002/hep.31589.
6
[Analysis of clinical characteristics of persistent HBeAg positivity in patients with chronic hepatitis B treated with nucleos(t)ide analogues].[核苷（酸）类似物治疗慢性乙型肝炎患者持续HBeAg阳性的临床特征分析]
Zhonghua Gan Zang Bing Za Zhi. 2024 Mar 20;32(3):193-200. doi: 10.3760/cma.j.cn501113-20230822-00065.
7
Reply: Benefits of stopping therapy in patients with cirrhotic hepatitis B, true effect, or residual confounding?回复：乙型肝炎肝硬化患者停止治疗的益处、真实效果还是残余混杂因素？
Hepatology. 2024 Mar 1;79(3):E97-E98. doi: 10.1097/HEP.0000000000000641. Epub 2023 Oct 20.
8
The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.慢性乙型肝炎患儿血清乙型肝炎表面抗原和乙型肝炎e抗原定量水平的重要性。
Turk J Gastroenterol. 2015 Jan;26(1):36-41. doi: 10.5152/tjg.2015.4636.
9
Natural history of decompensated cirrhosis with serum hepatitis B DNA < 2000 IU/mL: a retrospective study.血清乙型肝炎病毒 DNA<2000IU/ml 的失代偿性肝硬化自然史：一项回顾性研究。
BMC Gastroenterol. 2022 Nov 9;22(1):452. doi: 10.1186/s12876-022-02541-1.
10
Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.HBeAg阴性患者中与晚期肝病相关的乙肝病毒前S区缺失及复杂突变
Gastroenterology. 2007 Nov;133(5):1466-74. doi: 10.1053/j.gastro.2007.09.002. Epub 2007 Sep 6.

引用本文的文献

1
Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B Cure.慢性乙型肝炎中继续抗病毒治疗与停止治疗的临床影响：一项对乙肝治愈有启示的建模研究
J Viral Hepat. 2025 Oct;32(10):e70079. doi: 10.1111/jvh.70079.